MetLife Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$265K	Sell	96,652 -33,083	-26%	-$105K	﹤0.01%	2080
2025 Q4	$480K	Buy	129,735 +23,259	+22%	+$75.2K	﹤0.01%	1807
2025 Q3	$282K	Sell	106,476 -16,027	-13%	-$31K	﹤0.01%	2120
2025 Q2	$121K	Buy	122,503 +47,717	+64%	+$47.8K	﹤0.01%	2450
2025 Q1	$108K	Sell	74,786 -42,946	-36%	-$79.1K	﹤0.01%	2491
2024 Q4	$259K	Buy	117,732 +46,682	+66%	+$109K	﹤0.01%	2164
2024 Q3	$117K	Buy	71,050 +22,734	+47%	+$45.9K	﹤0.01%	2565
2024 Q2	$107K	Buy	+48,316	New	+$114K	﹤0.01%	2571
2023 Q2	–	Sell	-13,642	Closed	-$21.7K	–	2954
2023 Q1	$21.7K	Sell	13,642 -21,044	-61%	-$109K	﹤0.01%	2771
2022 Q4	$216K	Hold	34,686	–	–	﹤0.01%	2202
2022 Q3	$232K	Buy	34,686 +4,925	+17%	+$33.8K	﹤0.01%	2197
2022 Q2	$189K	Sell	29,761 -5,349	-15%	-$30.3K	﹤0.01%	2362
2022 Q1	$163K	Buy	+35,110	New	+$151K	﹤0.01%	2474
2021 Q4	–	Sell	-5,894	Closed	-$71K	–	2519
2021 Q3	$71K	Sell	5,894 -6,792	-54%	-$98.9K	﹤0.01%	2512
2021 Q2	$268K	Hold	12,686	–	–	﹤0.01%	1965
2021 Q1	$356K	Hold	12,686	–	–	﹤0.01%	1716
2020 Q4	$330K	Hold	12,686	–	–	﹤0.01%	1707
2020 Q3	$472K	Hold	12,686	–	–	0.01%	1392
2020 Q2	$651K	Buy	12,686 +1,785	+16%	+$74.7K	0.01%	1239
2020 Q1	$344K	Hold	10,901	–	–	﹤0.01%	1418
2019 Q4	$650K	Hold	10,901	–	–	0.01%	1311
2019 Q3	$400K	Hold	10,901	–	–	﹤0.01%	1546
2019 Q2	$507K	Hold	10,901	–	–	0.01%	1472
2019 Q1	$438K	Hold	10,901	–	–	﹤0.01%	1537
2018 Q4	$501K	Hold	10,901	–	–	0.01%	1369
2018 Q3	$484K	Hold	10,901	–	–	0.01%	1571
2018 Q2	$427K	Buy	10,901 +3,363	+45%	+$170K	0.01%	1499
2018 Q1	$545K	Hold	7,538	–	–	0.01%	1323
2017 Q4	$496K	Buy	+7,538	New	+$406K	0.01%	1392